Epidermal growth factor treatment of A431 cells alters the binding capacity and electrophoretic mobility of the cytoskeletally associated epidermal growth factor receptor
- PMID: 1990020
- DOI: 10.1002/jcp.1041460109
Epidermal growth factor treatment of A431 cells alters the binding capacity and electrophoretic mobility of the cytoskeletally associated epidermal growth factor receptor
Abstract
The epidermal growth factor (EGF) receptor interacts with structural elements of A431 cells and remains associated with the cytoskeleton following extraction with nonionic detergents. Extraction of cells with 0.15% Triton X-100 resulted in detection of only approximately 40% of the EGF binding sites on the cytoskeleton. If the cells were exposed to EGF prior to extraction, approximately twofold higher levels of low-affinity EGF binding sites were detected. The difference in number of EGF binding sites was not a consequence of differences in numbers of EGF receptors associated with the cytoskeleton; equal amounts of 35S-labeled receptor were immunoprecipitated from the cytoskeletons of both control and EGF-treated cells. The effect of EGF pretreatment on binding activity was coincident with a change in the mobility of the receptor from a doublet of Mr approximately 160-180 kDa to a single sharp band at 180 kDa. The alteration in receptor mobility was not a simple consequence of receptor phosphorylation in that the alteration was not reversed by alkaline phosphatase treatment, nor was the shift produced by treatment of the cells with phorbol ester. The two EGF receptor species demonstrated differential susceptibility to V8 proteinase digestion. The EGF-induced 180 kDa species was preferentially digested by the proteinase relative to the 160 kDa species, indicating that EGF binding results in a conformational change in the receptor. The EGF-mediated preservation of binding activity and altered conformation may be related to receptor oligomerization.
Similar articles
-
Characterization of the epidermal growth factor receptor associated with cytoskeletons of A431 cells.J Cell Physiol. 1989 Aug;140(2):295-304. doi: 10.1002/jcp.1041400215. J Cell Physiol. 1989. PMID: 2745564
-
Ligand-induced association of epidermal growth factor receptor to the cytoskeleton of A431 cells.J Cell Biochem. 1989 Apr;39(4):455-65. doi: 10.1002/jcb.240390411. J Cell Biochem. 1989. PMID: 2722972
-
Tumor necrosis factor regulates tyrosine phosphorylation on epidermal growth factor receptors in A431 carcinoma cells: evidence for a distinct mechanism.Cell Growth Differ. 1992 May;3(5):259-68. Cell Growth Differ. 1992. PMID: 1378752
-
Effects of epidermal growth factor on transferrin receptor phosphorylation and surface expression in malignant epithelial cells.J Cell Physiol. 1987 Sep;132(3):492-500. doi: 10.1002/jcp.1041320311. J Cell Physiol. 1987. PMID: 3498729
-
The epidermal growth factor. A review of structural and functional relationships in the normal organism and in cancer cells.Tumour Biol. 1990;11(5):229-61. Tumour Biol. 1990. PMID: 2203137 Review.
Cited by
-
The EGF receptor is an actin-binding protein.J Cell Biol. 1992 Oct;119(2):349-55. doi: 10.1083/jcb.119.2.349. J Cell Biol. 1992. PMID: 1383230 Free PMC article.
-
Transglutaminase differentially regulates growth signalling in rat perivenous and periportal hepatocytes.Cell Prolif. 2006 Jun;39(3):183-93. doi: 10.1111/j.1365-2184.2006.00379.x. Cell Prolif. 2006. PMID: 16671996 Free PMC article.
-
Transglutaminase induced by epidermal growth factor negatively regulates the growth signal in primary cultured hepatocytes.Biochem J. 1996 Jan 1;313 ( Pt 1)(Pt 1):305-9. doi: 10.1042/bj3130305. Biochem J. 1996. PMID: 8546699 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials